Status:
COMPLETED
Auriculotemporal Nerve Block in TMJ Disorders
Lead Sponsor:
Tokat Gaziosmanpasa University
Conditions:
Temporomandibular Joint Disorders
Arthralgia of TMJ
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The retrospective study aimed to evaluate the efficacy of the Auriculotemporal Nerve Block (ATNB) in achieving unrestricted mouth opening amount and in reducing the pain scores in those patients diagn...
Detailed Description
The records of 410 patients referred to the Department of Oral and Maxillofacial Surgery with TMD symptoms were reviewed to determine the treatment modalities used and their outcomes. The subjects wer...
Eligibility Criteria
Inclusion
- Underwent non-invasive therapies (occlusal stabilization splints, behavioral modifications, physical therapy, pharmacotherapy) but did not benefit from them and volunteered for the ATNB instead of invasive therapies (arthrocentesis, arthroscopy, and discectomy).
Exclusion
- Patients with
- Symptoms of the diseases possibly related to TMD (e.g., fibromyalgia, hypothyroidism, scleroderma, rheumatoid arthritis)
- Orofacial disorders that might have been responsible for the TMD symptoms (e.g., neuralgia, migraine, myositis, trauma, neuropathic pain, infections)
- Complications due to ATNB (e.g., temporary facial nerve palsy, hematoma, positive aspiration)
- History of invasive therapies or TMJ surgeries
Key Trial Info
Start Date :
January 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04827784
Start Date
January 15 2020
End Date
December 7 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokat Gaziosmanpasa University, Faculty of Dentistry
Tokat Province, Turkey (Türkiye), 60100